Limited partners in the oversubscribed fund include RBC, the Alberta Enterprise Corporation, and U.S. firm Alexandria Venture Investments and Paris-based Cathay Capital. RBC’s investment was led by RBC Capital Markets and RBCx, its new tech-focused lending platform that launched earlier this week. (The Logic)

Talking point: This is Amplitude’s second fund. The Montreal-based firm focuses on healthtech companies with the potential to reach valuations over a billion dollars. The raise highlights a new stage of maturity for Canada’s healthtech ecosystem. The firm started as a BDC Capital fund, through which the Crown corporation was meant to bolster the industry with high-risk investments that private-sector funders weren’t yet willing to make. Amplitude spun out of BDC once the private sector could support it (BDC remains an LP), and the firm launched its first private fund in 2019. The pandemic has boosted healthtech, with investments in the pharmaceutical and biotech sectors, as well as health-care-services firms, surging in 2020.